ET-1 also plays critical roles in psoriasis and Prurigo Nodularis, and ETAR antagonist ambrisentan improved the symptom in psoriasiform dermatitis in a mouse model [91], highlighting their possible anti-pruritic potential by antagonizing ET-1 pathway. Here, EDN1 is linked to prurigo nodularis.